
U.S. Government Acknowledges Medical Value of Cannabis, Paving Way for Rescheduling
The U.S. government's recognition of cannabis's medical value marks a pivotal policy shift, initiating its reclassification from Schedule I to Schedule III
- •U.S. government acknowledges cannabis's medical value, initiating rescheduling to Schedule III
- •Rescheduling could alleviate tax burdens on cannabis businesses under IRS code section 280E
- •Cannabis research opportunities may expand with fewer regulatory barriers under Schedule III
by The Government Admits Cannabis Has Medical Value. Now Comes the Fine Print



















